Article
US FTC orders Illumina to divest cancer detection test maker Grail
Rating:
0.0
Views:
27
Likes:
1
Library:
1
The U.S. Federal Trade Commission (FTC) on Monday ordered Illumina to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value